131 related articles for article (PubMed ID: 26706474)
1. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.
Yang Y; Seok MJ; Kim YE; Choi Y; Song JJ; Sulistio YA; Kim SH; Chang MY; Oh SJ; Nam MH; Kim YK; Kim TG; Im HI; Koh SH; Lee SH
Mol Psychiatry; 2023 Dec; 28(12):5359-5374. PubMed ID: 35902630
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-Conjugated Melittin-Loaded L-Arginine-Coated Iron Oxide Nanoparticles for Mitigating Beta-Amyloid Pathology of the 5XFAD Mouse Brain.
Choi M; Ryu J; Vu HD; Kim D; Youn YJ; Park MH; Huynh PT; Hwang GB; Youn SW; Jeong YH
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834402
[TBL] [Abstract][Full Text] [Related]
4. Liposome delivery systems for the treatment of Alzheimer's disease.
Ross C; Taylor M; Fullwood N; Allsop D
Int J Nanomedicine; 2018; 13():8507-8522. PubMed ID: 30587974
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
[TBL] [Abstract][Full Text] [Related]
6. Combining Multifunctional Delivery System with Blood-Brain Barrier Reversible Opening Strategy for the Enhanced Treatment of Alzheimer's Disease.
Ke J; Yu C; Li S; Hong Y; Xu Y; Wang K; Meng T; Ping Y; Fu Q; Yuan H; Hu F
Adv Healthc Mater; 2024 Mar; 13(8):e2302939. PubMed ID: 38117094
[TBL] [Abstract][Full Text] [Related]
7. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.
Zorkina Y; Abramova O; Ushakova V; Morozova A; Zubkov E; Valikhov M; Melnikov P; Majouga A; Chekhonin V
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202839
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment.
Mohebichamkhorami F; Faizi M; Mahmoudifard M; Hajikarim-Hamedani A; Mohseni SS; Heidari A; Ghane Y; Khoramjouy M; Khayati M; Ghasemi R; Zali H; Hosseinzadeh S; Mostafavi E
Small; 2023 Oct; 19(40):e2207626. PubMed ID: 37309299
[TBL] [Abstract][Full Text] [Related]
9. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
[TBL] [Abstract][Full Text] [Related]
10. Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments.
Rathnam SS; Deepak T; Sahoo BN; Meena T; Singh Y; Joshi A
J Pharmacol Exp Ther; 2024 Jan; 388(1):39-53. PubMed ID: 37875308
[TBL] [Abstract][Full Text] [Related]
11. Design and preparation of naringenin loaded functional biomimetic nano-drug delivery system for Alzheimer's disease.
Yan C; Gu J; Yin S; Wu H; Lei X; Geng F; Zhang N; Wu X
J Drug Target; 2024 Dec; 32(1):80-92. PubMed ID: 38044844
[TBL] [Abstract][Full Text] [Related]
12. Brain-Penetrating and Disease Site-Targeting Manganese Dioxide-Polymer-Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways.
Park E; Li LY; He C; Abbasi AZ; Ahmed T; Foltz WD; O'Flaherty R; Zain M; Bonin RP; Rauth AM; Fraser PE; Henderson JT; Wu XY
Adv Sci (Weinh); 2023 Apr; 10(12):e2207238. PubMed ID: 36808713
[TBL] [Abstract][Full Text] [Related]
13. Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment.
Ruan S; Li J; Ruan H; Xia Q; Hou X; Wang Z; Guo T; Zhu C; Feng N; Zhang Y
J Control Release; 2024 Feb; 366():712-731. PubMed ID: 38219911
[TBL] [Abstract][Full Text] [Related]
14. Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy.
Liu Y; Xia X; Zheng M; Shi B
Adv Mater; 2024 May; ():e2314354. PubMed ID: 38778446
[TBL] [Abstract][Full Text] [Related]
15. A High-Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors.
Liu Y; Du J; Choi JS; Chen KJ; Hou S; Yan M; Lin WY; Chen KS; Ro T; Lipshutz GS; Wu L; Shi L; Lu Y; Tseng HR; Wang H
Angew Chem Int Ed Engl; 2016 Jan; 55(1):169-73. PubMed ID: 26768819
[TBL] [Abstract][Full Text] [Related]
16. Bioreducible Gene Delivery Platform that Promotes Intracellular Payload Release and Widespread Brain Dispersion.
Rao D; Kwak G; Wang H; Eberhart CG; Hanes J; Suk JS
ACS Biomater Sci Eng; 2023 Aug; 9(8):4567-4572. PubMed ID: 37523785
[TBL] [Abstract][Full Text] [Related]
17. Non-Viral Targeted Nucleic Acid Delivery: Apply Sequences for Optimization.
Wang Y; Wagner E
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32961908
[TBL] [Abstract][Full Text] [Related]
18. Peptide-metal nanohybrids (PMN): Promising entities for combating neurological maladies.
Kour A; Panda HS; Singh IR; Kumar A; Panda JJ
Adv Colloid Interface Sci; 2023 Aug; 318():102954. PubMed ID: 37487364
[TBL] [Abstract][Full Text] [Related]
19. Polymeric Nanoparticles for Drug Delivery.
Beach MA; Nayanathara U; Gao Y; Zhang C; Xiong Y; Wang Y; Such GK
Chem Rev; 2024 May; 124(9):5505-5616. PubMed ID: 38626459
[TBL] [Abstract][Full Text] [Related]
20. Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases.
Tsakiri M; Tsichlis I; Zivko C; Demetzos C; Mahairaki V
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
